NEW YORK (GenomeWeb News) –  The US Food and Drug Administration has cleared a Cepheid test designed to help physicians detect viral meningitis within two-and-a-half hours, the FDA said today.
 
News of the clearance caused shares in Cepheid to trade up 7 percent today at $9.22 in the mid-afternoon.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.